S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:ITOS

iTeos Therapeutics News Headlines

$18.59
+1.64 (+9.68%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.66
$18.68
50-Day Range
$16.92
$37.00
52-Week Range
$16.35
$52.43
Volume
619,539 shs
Average Volume
571,056 shs
Market Capitalization
$660.69 million
P/E Ratio
2.38
Dividend Yield
N/A
Beta
1.94
Get iTeos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

iTeos Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ITOS
News Sentiment

1.08

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ITOS Articles
This Week

6

1

ITOS Articles
Average Week



iTeos Therapeutics (NASDAQ:ITOS) News Headlines Today

SourceHeadline
marketbeat.com logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Up 35.0% in April
marketbeat.com - May 16 at 8:37 AM
MarketBeat logoiTeos Therapeutics (NASDAQ:ITOS) Shares Gap Up to $18.30
americanbankingnews.com - May 19 at 5:14 AM
MarketBeat logoiTeos Therapeutics (NASDAQ:ITOS) vs. Eiger BioPharmaceuticals (NASDAQ:EIGR) Critical Comparison
americanbankingnews.com - May 17 at 2:40 AM
finance.yahoo.com logoForecast: Analysts Think iTeos Therapeutics, Inc.'s (NASDAQ:ITOS) Business Prospects Have Improved Drastically
finance.yahoo.com - May 16 at 10:37 AM
MarketBeat logoiTeos Therapeutics (NASDAQ:ITOS) Stock Price Down 2.5%
americanbankingnews.com - May 15 at 3:36 AM
seekingalpha.com logoBlue Water Vaccines, Oscar Health top healthcare gainers, Inovio, iTeos lead losers' pack
seekingalpha.com - May 13 at 10:45 PM
MarketBeat logoAaron I. Davis Sells 225,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock
americanbankingnews.com - May 13 at 4:22 AM
MarketBeat logoAaron I. Davis Sells 338,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock
americanbankingnews.com - May 13 at 4:22 AM
finance.yahoo.com logoITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 13 at 12:15 AM
finance.yahoo.com logoiTeos Reports First Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - May 12 at 5:54 PM
MarketBeat logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) to Post Q3 2022 Earnings of $2.77 Per Share, SVB Leerink Forecasts
americanbankingnews.com - May 12 at 2:50 AM
finance.yahoo.com logoBiotech Stocks Hammered On Roche's Unexpected Failure In Lung Cancer
finance.yahoo.com - May 11 at 4:52 PM
finance.yahoo.com logoRecent 8.9% pullback isn't enough to hurt long-term iTeos Therapeutics (NASDAQ:ITOS) shareholders, they're still up 13% over 1 year
finance.yahoo.com - May 11 at 11:51 AM
finance.yahoo.com logoWhy Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others
finance.yahoo.com - May 11 at 11:51 AM
MarketBeat logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Forecasted to Earn Q1 2022 Earnings of $0.96 Per Share
americanbankingnews.com - May 11 at 1:48 AM
MarketBeat logoAaron I. Davis Sells 100,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock
americanbankingnews.com - May 3 at 4:44 AM
MarketBeat logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Aaron I. Davis Sells 150,000 Shares
americanbankingnews.com - May 3 at 4:13 AM
MarketBeat logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Aaron I. Davis Sells 100,000 Shares of Stock
americanbankingnews.com - May 3 at 4:13 AM
MarketBeat logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Expected to Announce Quarterly Sales of $63.30 Million
americanbankingnews.com - May 3 at 3:38 AM
finanznachrichten.de logoInnoSkel: Innoskel Appoints Dr Michel Detheux as Chairman
finanznachrichten.de - April 12 at 5:33 AM
finance.yahoo.com logoInnoskel Appoints Dr Michel Detheux as Chairman
finance.yahoo.com - April 12 at 5:33 AM
finance.yahoo.com logoiTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022
finance.yahoo.com - April 8 at 6:54 PM
finance.yahoo.com logoAnalysts Just Slashed Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) EPS Numbers
finance.yahoo.com - March 26 at 5:41 PM
finance.yahoo.com logoITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates
finance.yahoo.com - March 23 at 11:54 PM
finance.yahoo.com logoiTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - March 23 at 6:54 PM
finanznachrichten.de logoiTeos Therapeutics Inc.: iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer
finanznachrichten.de - January 10 at 11:25 AM
finance.yahoo.com logoiTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer
finance.yahoo.com - January 10 at 11:25 AM
insidertrades.com logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Major Shareholder Bioventures 2018 L.P. Mpm Sells 128,550 Shares
insidertrades.com - January 6 at 6:19 PM
nasdaq.com logoFirst Week of July 15th Options Trading For iTeos Therapeutics
nasdaq.com - January 4 at 12:30 PM
finanznachrichten.de logoiTeos Therapeutics Inc.: iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference
finanznachrichten.de - January 3 at 6:02 PM
finance.yahoo.com logoWhy iTeos Therapeutics Topped the Market Today
finance.yahoo.com - January 3 at 6:02 PM
finance.yahoo.com logoITeos Therapeutics Inc Insiders are Selling. Investors Should Take Notice
finance.yahoo.com - December 29 at 2:35 PM
nasdaq.com logoITeos Therapeutics Inc Shares Near 52-Week High - Market Mover
nasdaq.com - December 26 at 8:44 AM
finance.yahoo.com logoIteos Therapeutics Inc (ITOS) CEO Michel Detheux Sold $2 million of Shares
finance.yahoo.com - December 23 at 10:33 AM
finance.yahoo.com logoiTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
finance.yahoo.com - December 9 at 6:14 PM
finanznachrichten.de logoOna Therapeutics: ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors
finanznachrichten.de - December 3 at 8:28 PM
ca.finance.yahoo.com logoONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors
ca.finance.yahoo.com - December 3 at 8:28 PM
finance.yahoo.com logoNotable Iteos Therapeutics Insider Trades $1.1M In Company Stock
finance.yahoo.com - November 22 at 3:50 PM
finance.yahoo.com logoWhy iTeos Therapeutics, Inc. (ITOS) Might be Well Poised for a Surge
finance.yahoo.com - November 16 at 6:14 PM
finance.yahoo.com logoWall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 53%: Here's is How to Trade
finance.yahoo.com - November 16 at 1:14 PM
finanznachrichten.de logoiTeos Therapeutics Inc.: iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
finanznachrichten.de - November 12 at 7:29 AM
finance.yahoo.com logoITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 11 at 12:02 AM
finance.yahoo.com logoiTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - November 10 at 7:02 PM
finance.yahoo.com logoChief Executive Officer Of Iteos Therapeutics Sold $590K In Stock
finance.yahoo.com - November 4 at 6:24 PM
finance.yahoo.com logoiTeos to Report Third Quarter 2021 Financial Results on November 10, 2021
finance.yahoo.com - November 3 at 9:47 AM
nasdaq.com logoWe Think iTeos Therapeutics (NASDAQ:ITOS) Can Afford To Drive Business Growth
nasdaq.com - October 18 at 11:14 AM
finance.yahoo.com logoWe're Not Very Worried About iTeos Therapeutics' (NASDAQ:ITOS) Cash Burn Rate
finance.yahoo.com - October 18 at 11:14 AM
benzinga.com logoChief Executive Officer Of Iteos Therapeutics Sold $None In Stock
benzinga.com - September 29 at 2:27 AM
benzinga.com logoChief Executive Officer Of Iteos Therapeutics Sold $180K In Stock
benzinga.com - September 29 at 2:27 AM
nasdaq.com logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Could Be Less Than A Year Away From Profitability
nasdaq.com - September 3 at 8:24 AM
finance.yahoo.com logoiTeos Therapeutics, Inc. (NASDAQ:ITOS) Is About To Turn The Corner
finance.yahoo.com - September 2 at 5:24 PM
Get iTeos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.